Bausch + Lomb Confirms It Is Exploring a Potential Sale [BNN Bloomberg (Canada)]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: BNN Bloomberg
The company said a sale was “one of several options being explored to complete a full separation from Bausch Health Companies Inc.,” in a statement on Thursday. “That process is ongoing, and there can be no assurance that it will result in a transaction.” The company said it typically didn't comment on deal negotiations but wanted to issue a response to a request for information from the Canadian Investment Regulatory Organization. “CIRO requested confirmation of a potential sale process given stock volatility often associated with market rumors. Bausch + Lomb does not intend to provide additional detail until further disclosure is appropriate or necessary,” the company said. The company is traded on both the New York Stock Exchange and Toronto Stock Exchange. The shares have gained 6.5% this year through Wednesday's close in New York. The company's stock tumbled yesterday after the Financial Times reported that Blackstone could pull out of a joint takeover bid for the eye care c
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb Co. (NYSE: BLCO) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $18.00 price target on the stock.MarketBeat
- Bausch + Lomb Co. (NYSE: BLCO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.MarketBeat
- Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Responds to Rumors of a Potential SaleBusiness Wire
- Bausch + Lomb down after report that Blackstone could back away from takeover bid [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 10/30/24 - Beat
BLCO
Sec Filings
- 11/1/24 - Form 8-K
- 10/30/24 - Form 10-Q
- 10/30/24 - Form 8-K
- BLCO's page on the SEC website